Geranylgeranyl transferase 1 inhibitor GGTI‑298 enhances the anticancer effect of gefitinib-Reference-Cited by-同舟云学术

Geranylgeranyl transferase 1 inhibitor GGTI‑298 enhances the anticancer effect of gefitinib

Published:2018-08-09 Issue: Volume: Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Report

Author:

Liu Bi‑Sheng¹,Dai Xin‑Yu¹,Xia Hong‑Wei²,Xu Huan‑Ji¹,Tang Qiu‑Lin²,Gong Qi‑Yong³,Nie Yong‑Zhan⁴,Bi Feng¹

Affiliation:

1. Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China

2. Laboratory of Molecular Targeted Therapy in Oncology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China

3. Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China

4. State Key Laboratory of Cancer Biology and Xijing Hospital of Digest Diseases, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

2. Targeting the “undruggable” cancer driver genes: Ras, myc, and tp53;BIOCELL;2023

3. Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs;Biochemical Pharmacology;2022-02

4. Molecular and Pharmacological Characterization of the Interaction between Human Geranylgeranyltransferase Type I and Ras-Related Protein Rap1B;International Journal of Molecular Sciences;2021-03-02

5. Lipid Metabolism and Resistance to Anticancer Treatment;Biology;2020-12-16